FATE
#3349
Fate Therapeutics, Inc. - Common Stock
2.4 3 USD
-0.04%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-4.33%
Monthly Change
+2.97%
6 month change
+67.59%
Year Change
+133.65%
Previous Close
2.5 4
Open
2.4 3
Low
2.4 3
High
2.4 3
Volume
32
Financials
- Market Capitalization 291.16 M
- Employee 161
- Founded 2007
- CEO Scott Wolchko
- Website www.fatetherapeutics.com
- Headquarter California, United States
- FIGI BBG000QP35H2
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.85
Price to sales ratio
17.56
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3341 |  FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.85 USD | 0.00% | +0.26% | +7.54% | -39.84% | 293.74 M USD | ||
| 3344 |  TTRX Turn Therapeutics Inc. - Common Stock | 9.84 USD | -2.67% | +4.79% | +31.55% | -1.60% | 293.11 M USD | ||
| 3351 |  RNAC Cartesian Therapeutics, Inc. - Common Stock | 9.60 USD | -3.71% | -4.48% | +29.38% | +4.80% | 290.45 M USD | ||
| 3367 |  LCTX Lineage Cell Therapeutics, Inc. Common Stock | 1.12 USD | -4.27% | +3.70% | +5.66% | -34.77% | 283.26 M USD |
Frequently asked questions about Fate Therapeutics, Inc.
What is the Fate Therapeutics, Inc. stock price today?
The current price of Fate Therapeutics, Inc. (FATE) is 2.43. Over the past 24 hours, the stock has changed by -4.33%. Follow the FATE chart for real-time price dynamics.
What is the stock ticker of Fate Therapeutics, Inc.?
Fate Therapeutics, Inc. trades under the ticker FATE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Fate Therapeutics, Inc. stock going up?
FATE has changed by +4.29% over the last week, +2.97% over the last month, and +133.65% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Fate Therapeutics, Inc.?
Fate Therapeutics, Inc. currently has a market capitalization of 291.16 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Fate Therapeutics, Inc. earnings last quarter?
Last quarter, Fate Therapeutics, Inc. reported earnings of -0.25 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Fate Therapeutics, Inc. revenue for the last quarter?
Fate Therapeutics, Inc. reported quarterly revenue of 2.08 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Fate Therapeutics, Inc. net income for the last quarter?
Fate Therapeutics, Inc. reported net income of -30.16 M for the last quarter. The previous quarter showed -31.21 M, which means net income changed by +3.38%.
How many employees does Fate Therapeutics, Inc. have?
As of the latest available data, Fate Therapeutics, Inc. has 161 employees. Workforce size can provide additional context about the company's scale and operations.
What is Fate Therapeutics, Inc. EBITDA?
Fate Therapeutics, Inc. EBITDA is -28.35 M, and its EBITDA margin is -1 361.86%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Fate Therapeutics, Inc. stock?
You can buy Fate Therapeutics, Inc. (FATE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Fate Therapeutics, Inc. stock?
Investing in Fate Therapeutics, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the FATE chart and related analysis on metatrader.com as part of your research.